002086Oriental OceanSZSE

Shandong Oriental Ocean Sci-tech Co., Ltd.

东方海洋

002086

Shenzhen Stock Exchange

BoardMain Board of Shenzhen Stock Exchange
IndustryFishery
ISINCNE000001PG9
ListedNovember 28, 2006
Websitewww.dfhy.cc
IR Emaildfhy@dfhy.cc
Phone(+86)535-6729111
Sourcecninfo.com.cn
AddressNo. 18, Aokema Avenue, Laishan District, Yantai, Shandong

Company Overview

Shandong Oriental Ocean Sci-Tech Co., Ltd. is a Chinese company listed on the Shenzhen Stock Exchange since 2006. It operates primarily in the fishery sector, focusing on seawater breeding, aquatic products processing, biotechnology, bonded warehousing logistics, and in vitro diagnostic reagents. The company is recognized as a national high-tech enterprise and a key player in agricultural industrialization, integrating various aspects of mariculture, biological products, pharmaceutical intermediates, scientific research, and international trade. The company's main business lines include the breeding, processing, and marketing of rare fish, particularly sea cucumbers, as well as the processing and sale of various frozen fish fillets. Additionally, it engages in the research, development, production, and sale of in vitro diagnostic reagents and testing services. Shandong Oriental Ocean leverages its competitive advantages in resources, technology, and research to enhance its market position, focusing on sustainable development through its Marine Business Division and Big Health Business Division, supported by multiple national and provincial R&D platforms.

AI-generated from company disclosures and CNInfo data.

Company Profile

The company is a national-level aquatic fine breed farm, boasting comprehensive core competitive advantages in resources, technology, scientific research, talent, scale, quality control, and brand. Based on its existing competitive advantages and relying on various national preferential and supportive policies, the Marine Business Division highlights the advantages of large-scale, standardized, and high-precision development in processing operations, while the breeding business emphasizes the characteristics of pollution-free, high-quality, and highly safe. The Big Health Business Division continuously enhances its scientific research capabilities, accelerates the improvement of industrial layout, and builds market sales channels.Rooted in these two industries, the company seizes both domestic and international markets, enhances brand awareness and its core competitiveness, and strives to achieve sustainable development driven by dual engines (the two business divisions) and technological innovation. Currently, the company has 7 national R&D platforms, 11 provincial R&D platforms, and 6 industry-university-research cooperation platforms. Relying on these technological R&D platforms, the company has gradually built a technological innovation system that integrates key technological project research, breakthroughs in core technologies, development of original applied technologies, and transformation of research achievements.

44 announcements tracked· Last: August 17, 2026

Key Financials

As of 2026-08-15T00:00:00.000+00:00
Revenue¥78.4M
Net Profit-¥11.3M
ROE-0.89%
Debt Ratio19.65%
Monetary Funds¥241.5M
Receivables¥66.5M
Goodwill¥3.9M
Total Shares1.96bn

Announcements

44 totalCSV

Notes & Comments

Sign in to leave a comment or private note.

No notes or comments yet.